Last updated on April 2019

A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study


Brief description of study

The purpose of this study is to collect long term safety data in subjects who are continuing to derive clinical benefit from treatment with Enzalutamide from the subjects participation in an enzalutamide clinical study sponsored by Astellas or Medivation (i.e., parent study) which has completed, at a minimum, the primary analysis or the study specified evaluation period.

Detailed Study Description

Subjects should continue on the treatment regimen that the subject was receiving in the prior study. Dose changes of any of the prior therapies subjects were receiving on the previous protocol are allowed after medical monitor approval. The day 1 visit for this study should coincide with the last treatment visit for the study the subject will be enrolling from ( 7 days post last visit of parent study). The subjects will be followed according to the local institution's standard of care and will be required to return to the institution every 12 weeks ( 7 days) to review adverse events (AEs), collect concomitant medications, confirm that no discontinuation criteria are met, return all dispensed study drug and to receive more study drug if applicable. All AEs (new and ongoing from the study the subject is enrolling from) and Serious Adverse Events (SAEs) (including death), will be collected from the time the subject signs the consent form until the end of study visit.

Clinical Study Identifier: NCT02960022

Find a site near you

Start Over

Site US10011

Tucson, AZ United States
  Connect »

Site US10009

Los Angeles, CA United States
  Connect »

Site US10008

San Bernardino, CA United States
  Connect »

Site US10001

Aurora, CO United States
  Connect »

Site US10017

Denver, CO United States
  Connect »

Site US10049

Daytona Beach, FL United States
  Connect »

Site US10048

Jacksonville, FL United States
  Connect »

Site US10002

Chicago, IL United States
  Connect »

Site US10007

Jeffersonville, IN United States
  Connect »

Site US10004

Hackensack, NJ United States
  Connect »

Site US10030

Chapel Hill, NC United States
  Connect »

Site US10020

Concord, NC United States
  Connect »

Site US10031

Greensboro, NC United States
  Connect »

Site US10035

Cincinnati, OH United States
  Connect »

Site US10022

Springfield, OR United States
  Connect »

Site US10027

Lancaster, PA United States
  Connect »

Site US10005

Pittsburgh, PA United States
  Connect »

Site US10018

Charleston, SC United States
  Connect »

Site US10003

Myrtle Beach, SC United States
  Connect »

Site US10041

Nashville, TN United States
  Connect »

Site US10010

Dallas, TX United States
  Connect »

Site US10014

Norfolk, VA United States
  Connect »

Site US10015

Virginia Beach, VA United States
  Connect »

Site US10021

Madison, WI United States
  Connect »

Site BE32007

Hasselt, Belgium
  Connect »

Site BE32002

Kortrijk, Belgium
  Connect »

Site BE32004

Brussels, Belgium
  Connect »

Site BE32008

Leuven, Belgium
  Connect »

Site BE32003

Turnhout, Belgium
  Connect »

Site CA15003

Kingston, ON Canada
  Connect »

Site CA15001

Granby, QC Canada
  Connect »

Site CZ42002

Olomouc, Czechia
  Connect »

Site CZ42001

Praha 6, Czechia
  Connect »

Site DK45002

Aalborg, Denmark
  Connect »

Site DK45003

Aarhus, Denmark
  Connect »

Site DK45001

Copenhagen, Denmark
  Connect »

Site DK45004

Herlev, Denmark
  Connect »

Site FR33008

La Roche sur Yon, France
  Connect »

Site FR33002

Lyon Cedex 3, France
  Connect »

Site FR33001

Nantes Saint Herblain Cedex, France
  Connect »

Site GE99501

Tbilisi, Georgia
  Connect »

Site DE49004

Nuertingen, Germany
  Connect »

Site DE49007

Waldshut-Tiengen, Germany
  Connect »

Site DE49006

Mannheim, Germany
  Connect »

Site DE49001

Duisburg, Germany
  Connect »

Site DE49003

Hamburg, Germany
  Connect »

Site MD37301

Chisinau, Moldova, Republic of
  Connect »

Site RU70001

Moscow, Russian Federation
  Connect »

Site ZA27001

George, South Africa
  Connect »

Site GB44004

Bristol, United Kingdom
  Connect »

Site GB44005

Cardiff, United Kingdom
  Connect »

Site GB44007

Manchester, United Kingdom
  Connect »

Site US10040

Los Angeles, CA United States
  Connect »

Site US10028

Stanford, CA United States
  Connect »

Site US10050

Washington, WA United States
  Connect »

Site US10029

Towson, MD United States
  Connect »

Site US10032

Saint Louis, MO United States
  Connect »

Site US10023

Omaha, NE United States
  Connect »

Site US10024

Garden City, NY United States
  Connect »

Site US10046

Winston-Salem, NC United States
  Connect »

Site US10034

Houston, TX United States
  Connect »

Site US10043

Houston, TX United States
  Connect »

Site US10038

Seattle, WA United States
  Connect »

Site FR33004

Villejuif, France
  Connect »

Site ES34003

Barcelona, Spain
  Connect »

Site GB44009

Bebington, United Kingdom
  Connect »

Site GB44003

Belfast, United Kingdom
  Connect »

Site GB44002

Glasgow, United Kingdom
  Connect »

Site GB44006

London, United Kingdom
  Connect »

Site GB44008

Northwood, Middlesex, United Kingdom
  Connect »

Site GB44001

Sutton, United Kingdom
  Connect »